Faculty profile

Murray Urowitz

ResearcherRheumatologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Murray Urowitz

Researcher

Rheumatology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
22 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

4,046

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Disease Course Genetic Epidemiology Predictive Factors Risk Factors Sle Phenotype Systemic Lupus Erythematosus

Latest papers

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal of clinical epidemiology · 2026
Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.
Lupus science & medicine · 2026
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Annals of the rheumatic diseases · 2026

All 49 publications

Latest funding

The Lupus prEGnAnCY (LEGACY) Cohort
CIHR · 2017 · Co-investigator
$100,000
Defining Phenotypes in Systemic Lupus Erythematosus: towards an individualized approach
CIHR · 2016 · Nominated PI
$609,992
An international, multi-center, prospective, inception cohort study of neuropsychiatric systemic lupus erythematosus (NPSLE)
CIHR · 2012 · Co-investigator
$1,010,262

All 4 grants and awards

49 publications.

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Kaddoura R, Bernatsky S, Beauchamp ME, Guerra SF, Almeida-Brasil CC, Hanly JG, Urowitz M, Clarke AE, Ruiz-Irastorza G, Gordon C, Ramsey-Goldman R, Petri MA, Ginzler EM, Wallace DJ, Bae SC, Romero-Diaz J, Dooley MA, Peschken C, Isenberg D, Manzi S, Jacobsen S, Lim SS, Nived O, Jönsen A, Kamen DL, Aranow C, Sánchez-Guerrero J, Gladman DD, Fortin PR, Alarcón GS, Merrill JT, Kalunian K, Ramos-Casals M, Zoma AA, Askanase AD, Khamashta M, Bruce IN, Inanc M, Lukusa L, Abrahamowicz M

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112261 PMID: 41921830

Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.

Baker R, Whittall Garcia LP, Li Q, Kim M, Bonilla D, Gladman DD, Urowitz M, Touma Z, Wither J

Lupus science & medicine2026

DOI: 10.1136/lupus-2025-001724 PMID: 41714112

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.

Becker YLC, Boilard É, Rollet-Labelle E, Lood C, Julien AS, Abrahamowicz M, Allaeys I, Choi M, Leclerc J, Lévesque T, Urowitz M, Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Wallace D, Isenberg D, Rahman A, Merrill J, Gladman DD, Bruce IN, Petri M, Ginzler E, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcόn GS, van Vollenhoven R, Aranow C, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen D, Askanase A, Buyon J, Fortin PR

Annals of the rheumatic diseases2026

DOI: 10.1016/j.ard.2025.11.007 PMID: 41390302

Towards a minimal core dataset for systemic lupus erythematosus studies.

McDonald S, Teng J, Yang C, Barraclough M, Alarcon GS, Askanase AD, Bernatsky S, Clarke AE, Costedoat-Chalumeau N, Fu Q, Gladman DD, Hanly JG, Legge AC, Isenberg D, Kalunian K, Kamen DL, Petri MA, Rahman A, Sun C, Li T, Urowitz M, Voskuyl A, Wallace DJ, Zhang J, Bruce IN

Lupus science & medicine2025

DOI: 10.1136/lupus-2025-001595 PMID: 40987485

Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus.

Misztal MC, Liao F, Gold N, Cao J, Gladman DD, Touma Z, Wither J, Cook R, Urowitz M, Hiraki LT

Rheumatology (Oxford, England)2025

DOI: 10.1093/rheumatology/keaf093 PMID: 40036173

Second Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus.

Lucas AM, Miller C, Eudy A, Myers R, Wyatt CM, Wheeler S, Petri M, Fischer-Betz R, Mokbel A, Nalli C, Andreoli L, Tincani A, Molad Y, Balevic S, Gladman DD, Urowitz M, Clowse MEB

Kidney3602025

DOI: 10.34067/kid.0000000738 PMID: 39951346

Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis.

Whittall-Garcia LP, Naderinabi F, Gladman DD, Urowitz M, Touma Z, Konvalinka A, Wither J

Lupus science & medicine2024

DOI: 10.1136/lupus-2023-001038 PMID: 38177067

Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.

Whittall Garcia LP, Gladman DD, Urowitz M, Bonilla D, Schneider R, Touma Z, Wither J

Lupus science & medicine2024

DOI: 10.1136/lupus-2024-001347 PMID: 39613334

Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort.

Urowitz M, Georgiou ME, Touma Z, Su J, Diaz-Martinez JP, Fu Q, Levy RA, Gairy K, MacKinnon A, Anderson N, Juliao PC

Lupus science & medicine2024First author

DOI: 10.1136/lupus-2024-001264 PMID: 39608814

Different Immunologic Profiles Are Associated With Distinct Clinical Phenotypes in Longitudinally Observed Patients With Systemic Lupus Erythematosus.

Manion K, Muñoz-Grajales C, Kim M, Atenafu E, Faheem Z, Gladman DD, Urowitz M, Touma Z, Wither JE

Arthritis & rheumatology (Hoboken, N.J.)2024

DOI: 10.1002/art.42776 PMID: 38073017

Something wrong or missing on this profile? Suggest a correction

Murray Urowitz

Research

Latest papers

Latest funding

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.

Towards a minimal core dataset for systemic lupus erythematosus studies.

Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus.

Second Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus.

Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis.

Interferon-&#x3b1; as a biomarker to predict renal outcomes in lupus nephritis.

Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort.

Different Immunologic Profiles Are Associated With Distinct Clinical Phenotypes in Longitudinally Observed Patients With Systemic Lupus Erythematosus.

The Lupus prEGnAnCY (LEGACY) Cohort

Defining Phenotypes in Systemic Lupus Erythematosus: towards an individualized approach

An international, multi-center, prospective, inception cohort study of neuropsychiatric systemic lupus erythematosus (NPSLE)

The Metabolic Syndrome in Patients with Systemic Lupus Erythematosus (SLE): Clinical, Therapeutic and Genetic Determinants in an International Inception Cohort Registry

Frequent collaborators

Zahi Touma

Sasha Bernatsky

Sasha Bernatsky

Dafna Gladman

Christine Peschken

Joan Wither

John Hanly

Wendy Lou

Michal Abrahamowicz

Laura Whittall-Garcia

Evelyne Vinet

Arielle Mendel

Arielle Mendel

Eleanor Pullenayegum

Raja Bobba

Konstantinos Tselios

Heather Reich

Evelyne Vinet

May Choi

Andrea Knight

Richard Cook

Raphael Schneider

James Scholey

Nicole Anderson

Janet Pope

Celia Greenwood

Ana Konvalinka

Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.